What types of cancer commonly metastasize to the liver?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Common Cancers That Metastasize to the Liver

Colorectal cancer is the most common cancer that metastasizes to the liver, with approximately 50-60% of colorectal cancer patients developing liver metastases during the course of their disease. 1

Primary Cancers with High Rates of Liver Metastasis

Colorectal Cancer

  • The liver is the most common site of distant metastasis in colorectal cancer 1
  • 20-34% of patients present with synchronous liver metastases at initial diagnosis 2
  • An additional 40-50% develop metachronous liver metastases after primary tumor resection 2
  • In autopsy studies, more than 50% of patients who die from colorectal cancer have liver metastases 2
  • The liver is the only site of metastatic disease in approximately one-third of these patients 2

Other Common Primary Cancers That Metastasize to Liver

While colorectal cancer has the strongest predilection for liver metastasis, other common primary cancers that frequently metastasize to the liver include:

  • Lung cancer (second most common source of liver metastases)
  • Breast cancer
  • Pancreatic cancer
  • Gastric cancer
  • Esophageal cancer
  • Melanoma
  • Neuroendocrine tumors

Pathophysiology of Liver Metastasis

Portal Circulation Theory

  • The principal mode of colorectal cancer dissemination to the liver is via the portal venous system 2
  • Tumor cells from the primary colorectal cancer enter the portal circulation and are trapped in the hepatic sinusoids
  • This explains why the liver is often the first and only site of metastasis in many colorectal cancer patients

Prognostic Implications

  • Liver metastases are the cause of death in the majority of patients with metastatic colorectal cancer 1
  • Untreated hepatic metastases have a 5-year survival rate of less than 1% 1
  • Synchronous liver metastases (present at diagnosis) carry a worse prognosis than metachronous metastases (developing later) 2, 1
  • Patients with synchronous liver metastases typically have more sites of liver involvement and more bilobar metastases 2

Clinical Significance

  • Surgical resection of isolated hepatic metastases from colorectal cancer may be curative in select cases 2
  • Only 10-20% of patients with liver metastases are eligible for potentially curative resection 3
  • With modern surgical techniques and multimodal therapy, 5-year survival rates after hepatic resection range from 35-55% 3
  • Even with successful resection, the majority of patients will experience disease recurrence 3

Pitfalls and Caveats

  1. Missed Diagnosis: Always consider liver metastases in any patient with a history of colorectal cancer presenting with unexplained weight loss, abdominal pain, or abnormal liver function tests.

  2. Incomplete Evaluation: When colorectal cancer is diagnosed, comprehensive staging including liver imaging is essential, as 20-25% of patients have liver metastases at initial diagnosis.

  3. Overlooking Curative Options: Not all liver metastases are incurable - referral to specialized hepatobiliary centers should be considered for evaluation of potential surgical options.

  4. Synchronous vs. Metachronous: The timing of liver metastases has prognostic implications - synchronous metastases generally indicate more aggressive disease.

  5. Surveillance Importance: Regular follow-up with appropriate imaging for at least 3-5 years after primary colorectal cancer resection is critical, as most metachronous liver metastases develop within this timeframe.

References

Guideline

Colorectal Cancer Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.